Arylsulfatase B Improves Locomotor Function after Mouse Spinal Cord Injury

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Yoo, Myungsik ^a   Khaled, Muntasir ^a   Gibbs, Kurt M ^a   Kim, Jonghun ^a   Kowalewski, Björn ^b   Dierks, Thomas ^b   Schachner, Melitta ^a,c  

^a RUTGERS UNIVERSITY   (United States)

^b BIELEFELD UNIVERSITY   (Germany)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN ABC LYASE; DERMATAN SULFATE; GALSULFASE; N ACETYLGALACTOSAMINE 4 SULFATASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STABILITY; ENZYME THERAPY; FEMALE; IMMUNOGENICITY; IMMUNOREACTIVITY; LOCOMOTION; MOLECULAR DYNAMICS; MOUSE; NERVE FIBER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPINAL CORD INJURY; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; BACTERIAL PROTEINS; CHONDROITIN ABC LYASE; CHONDROITIN SULFATES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LOCOMOTION; MICE; N-ACETYLGALACTOSAMINE-4-SULFATASE; RECOMBINANT PROTEINS; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 84874776363     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057415     Document Type: Article

References (75)

1. Fawcett JW, Asher RA, (1999) The glial scar and central nervous system repair. Brain Res Bull 49: 377-391.
2. Raineteau O, Schwab ME, (2001) Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci 2: 263-273.
3. Fehlings MG (2008) Repair of the chronically injured human spinal cord. J Neurosurg Spine 8: 205-206; discussion 206-207.
4. Fitch MT, Silver J, (2008) CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 209: 294-301.
5. McKeon RJ, Jurynec MJ, Buck CR, (1999) The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci 19: 10778-10788.
6. Asher RA, Morgenstern DA, Fidler PS, Adcock KH, Oohira A, et al. (2000) Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 20: 2427-2438.
7. Jones LL, Margolis RU, Tuszynski MH, (2003) The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 182: 399-411.
8. Brittis PA, Canning DR, Silver J, (1992) Chondroitin sulfate as a regulator of neuronal patterning in the retina. Science 255: 733-736.
9. Silver J, (1994) Inhibitory molecules in development and regeneration. J Neurol 242: S22-24.
10. Wilson MT, Snow DM, (2000) Chondroitin sulfate proteoglycan expression pattern in hippocampal development: potential regulation of axon tract formation. J Comp Neurol 424: 532-546.
11. Cavalcante LA, Garcia-Abreu J, Mendes FA, Moura Neto V, Silva LC, et al. (2003) Sulfated proteoglycans as modulators of neuronal migration and axonal decussation in the developing midbrain. Braz J Med Biol Res 36: 993-1002.
12. Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, et al. (2002) Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298: 1248-1251.
13. Deepa SS, Carulli D, Galtrey C, Rhodes K, Fukuda J, et al. (2006) Composition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycans. J Biol Chem 281: 17789-17800.
14. Carulli D, Rhodes KE, Fawcett JW, (2007) Upregulation of aggrecan, link protein 1, and hyaluronan synthases during formation of perineuronal nets in the rat cerebellum. J Comp Neurol 501: 83-94.
15. Bovolenta P, Wandosell F, Nieto-Sampedro M, (1991) Neurite outgrowth over resting and reactive astrocytes. Restor Neurol Neurosci 2: 221-228.
16. Fitch MT, Doller C, Combs CK, Landreth GE, Silver J, (1999) Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci 19: 8182-8198.
17. Morgenstern DA, Asher RA, Fawcett JW, (2002) Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res 137: 313-332.
18. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT, (1994) A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13: 757-767.
19. McKeon RJ, Hoke A, Silver J, (1995) Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 136: 32-43.
20. Wang H, Katagiri Y, McCann TE, Unsworth E, Goldsmith P, et al. (2008) Chondroitin-4-sulfation negatively regulates axonal guidance and growth. J Cell Sci 121: 3083-3091.
21. Properzi F, Carulli D, Asher RA, Muir E, Camargo LM, et al. (2005) Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur J Neurosci 21: 378-390.
22. Butterfield KC, Caplan M, Panitch A, (2010) Identification and sequence composition characterization of chondroitin sulfate-binding peptides through peptide array screening. Biochemistry 49: 1549-1555.
23. Butterfield KC, Conovaloff A, Caplan M, Panitch A, (2010) Chondroitin sulfate-binding peptides block chondroitin 6-sulfate inhibition of cortical neurite growth. Neurosci Lett 478: 82-87.
24. Lin R, Rosahl TW, Whiting PJ, Fawcett JW, Kwok JC, (2011) 6-Sulphated chondroitins have a positive influence on axonal regeneration. PLoS One 6: e21499.
25. Liu J, Chau CH, Liu H, Jang BR, Li X, et al. (2006) Upregulation of chondroitin 6-sulphotransferase-1 facilitates Schwann cell migration during axonal growth. J Cell Sci 119: 933-942.
26. Gilbert RJ, McKeon RJ, Darr A, Calabro A, Hascall VC, et al. (2005) CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol Cell Neurosci 29: 545-558.
27. Karumbaiah L, Anand S, Thazhath R, Zhong Y, McKeon RJ, et al. (2011) Targeted downregulation of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase significantly mitigates chondroitin sulfate proteoglycan-mediated inhibition. Glia 59: 981-996.
28. Lin R, Kwok JC, Crespo D, Fawcett JW, (2008) Chondroitinase ABC has a long-lasting effect on chondroitin sulphate glycosaminoglycan content in the injured rat brain. J Neurochem 104: 400-408.
29. Prabhakar V, Capila I, Bosques CJ, Pojasek K, Sasisekharan R, (2005) Chondroitinase ABC I from Proteus vulgaris: cloning, recombinant expression and active site identification. Biochem J 386: 103-112.
30. Yick LW, Cheung PT, So KF, Wu W, (2003) Axonal regeneration of Clarke's neurons beyond the spinal cord injury scar after treatment with chondroitinase ABC. Exp Neurol 182: 160-168.
31. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, et al. (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416: 636-640.
32. Fouad K, Schnell L, Bunge MB, Schwab ME, Liebscher T, et al. (2005) Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci 25: 1169-1178.
33. Kim BG, Dai HN, Lynskey JV, McAtee M, Bregman BS, (2006) Degradation of chondroitin sulfate proteoglycans potentiates transplant-mediated axonal remodeling and functional recovery after spinal cord injury in adult rats. J Comp Neurol 497: 182-198.
34. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Schut D, Fehlings MG, (2010) Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 30: 1657-1676.
35. Garcia-Alias G, Lin R, Akrimi SF, Story D, Bradbury EJ, et al. (2008) Therapeutic time window for the application of chondroitinase ABC after spinal cord injury. Exp Neurol 210: 331-338.
36. Vink R, McIntosh TK, Weiner MW, Faden AI, (1987) Effects of traumatic brain injury on cerebral high-energy phosphates and pH: a 31P magnetic resonance spectroscopy study. J Cereb Blood Flow Metab 7: 563-571.
37. Huang PP, Young W, (1994) The effects of arterial blood gas values on lesion volumes in a graded rat spinal cord contusion model. J Neurotrauma 11: 547-562.
38. Xiong ZG, Zhu XM, Chu XP, Minami M, Hey J, et al. (2004) Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118: 687-698.
39. Hamai A, Hashimoto N, Mochizuki H, Kato F, Makiguchi Y, et al. (1997) Two distinct chondroitin sulfate ABC lyases. An endoeliminase yielding tetrasaccharides and an exoeliminase preferentially acting on oligosaccharides. J Biol Chem 272: 9123-9130.
40. Prabhakar V, Capila I, Soundararajan V, Raman R, Sasisekharan R, (2009) Recombinant expression, purification, and biochemical characterization of chondroitinase ABC II from Proteus vulgaris. J Biol Chem 284: 974-982.
41. Koshiishi I, Takenouchi M, Hasegawa T, Imanari T, (1998) Enzymatic method for the simultaneous determination of hyaluronan and chondroitin sulfates using high-performance liquid chromatography. Anal Biochem 265: 49-54.
42. Tester NJ, Plaas AH, Howland DR, (2007) Effect of body temperature on chondroitinase ABC's ability to cleave chondroitin sulfate glycosaminoglycans. J Neurosci Res 85: 1110-1118.
43. Lee H, McKeon RJ, Bellamkonda RV, (2010) Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci U S A 107: 3340-3345.
44. Wasserman SI, Austen KF, (1976) Arylsulfatase B of human lung. Isolation, characterization, and interaction with slow-reacting substance of anaphylaxis. J Clin Invest 57: 738-744.
45. Munoz-Rojas MV, Horovitz DD, Jardim LB, Raymundo M, Llerena JC Jr, et al. (2010) Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis. Mol Genet Metab 99: 346-350.
46. Harmatz P, Ketteridge D, Giugliani R, Guffon N, Teles EL, et al. (2005) Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Pediatrics 115: e681-689.
47. Harmatz P, Whitley CB, Waber L, Pais R, Steiner R, et al. (2004) Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr 144: 574-580.
48. Mitsunaga-Nakatsubo K, Kusunoki S, Kawakami H, Akasaka K, Akimoto Y, (2009) Cell-surface arylsulfatase A and B on sinusoidal endothelial cells, hepatocytes, and Kupffer cells in mammalian livers. Med Mol Morphol 42: 63-69.
49. Iseda T, Okuda T, Kane-Goldsmith N, Mathew M, Ahmed S, et al. (2008) Single, high-dose intraspinal injection of chondroitinase reduces glycosaminoglycans in injured spinal cord and promotes corticospinal axonal regrowth after hemisection but not contusion. J Neurotrauma 25: 334-349.
50. Caggiano AO, Zimber MP, Ganguly A, Blight AR, Gruskin EA, (2005) Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord. J Neurotrauma 22: 226-239.
51. Huang WC, Kuo WC, Cherng JH, Hsu SH, Chen PR, et al. (2006) Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem Biophys Res Commun 349: 963-968.
52. Deepa SS, Yamada S, Fukui S, Sugahara K, (2007) Structural determination of novel sulfated octasaccharides isolated from chondroitin sulfate of shark cartilage and their application for characterizing monoclonal antibody epitopes. Glycobiology 17: 631-645.
53. Yi JH, Katagiri Y, Susarla B, Figge D, Symes AJ, et al. (2012) Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice. J Comp Neurol 520: 3295-3313.
54. Skidmore MA, Guimond SE, Dumax-Vorzet AF, Yates EA, Turnbull JE, (2010) Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection. Nat Protoc 5: 1983-1992.
55. Gorham SD, Cantz M, (1978) Arylsulphatase B, an exo-sulphatase for chondroitin 4-sulphate tetrasaccharide. Hoppe Seylers Z Physiol Chem 359: 1811-1814.
56. Anson DS, Taylor JA, Bielicki J, Harper GS, Peters C, et al. (1992) Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem J 284 (Pt 3): 789-794.
57. Li F, Shetty AK, Sugahara K, (2007) Neuritogenic activity of chondroitin/dermatan sulfate hybrid chains of embryonic pig brain and their mimicry from shark liver. Involvement of the pleiotrophin and hepatocyte growth factor signaling pathways. J Biol Chem 282: 2956-2966.
58. Lamanna WC, Frese MA, Balleininger M, Dierks T, (2008) Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling. J Biol Chem 283: 27724-27735.
59. Schachtrup C, Ryu JK, Helmrick MJ, Vagena E, Galanakis DK, et al. (2010) Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage. J Neurosci 30: 5843-5854.
60. Susarla BT, Laing ED, Yu P, Katagiri Y, Geller HM, et al. (2011) Smad proteins differentially regulate transforming growth factor-beta-mediated induction of chondroitin sulfate proteoglycans. J Neurochem 119: 868-878.
61. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, et al. (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29: 13435-13444.
62. Shechter R, Raposo C, London A, Sagi I, Schwartz M, (2011) The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair. PLoS One 6: e27969.
63. Bradbury EJ, Carter LM, (2011) Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 84: 306-316.
64. Rolls A, Shechter R, Schwartz M, (2009) The bright side of the glial scar in CNS repair. Nat Rev Neurosci 10: 235-241.
65. Alilain WJ, Horn KP, Hu H, Dick TE, Silver J, (2011) Functional regeneration of respiratory pathways after spinal cord injury. Nature 475: 196-200.
66. Hawthorne AL, Hu H, Kundu B, Steinmetz MP, Wylie CJ, et al. (2011) The unusual response of serotonergic neurons after CNS Injury: lack of axonal dieback and enhanced sprouting within the inhibitory environment of the glial scar. J Neurosci 31: 5605-5616.
67. Giulian D, Robertson C, (1990) Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 27: 33-42.
68. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, et al. (1999) Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 158: 351-365.
69. Dierks T, Lecca MR, Schmidt B, von Figura K, (1998) Conversion of cysteine to formylglycine in eukaryotic sulfatases occurs by a common mechanism in the endoplasmic reticulum. FEBS Lett 423: 61-65.
70. Porter MT, Fluharty AL, Kihara H, (1969) Metachromatic leukodystrophy: arylsulfatase-A deficiency in skin fibroblast cultures. Proc Natl Acad Sci U S A 62: 887-891.
71. Knaust A, Schmidt B, Dierks T, von Bulow R, von Figura K, (1998) Residues critical for formylglycine formation and/or catalytic activity of arylsulfatase A. Biochemistry. 37: 13941-13946.
72. Curtis R, Green D, Lindsay RM, Wilkin GP, (1993) Up-regulation of GAP-43 and growth of axons in rat spinal cord after compression injury. J Neurocytol 22: 51-64.
73. Steward O, Zheng B, Tessier-Lavigne M, (2003) False resurrections: distinguishing regenerated from spared axons in the injured central nervous system. J Comp Neurol 459: 1-8.
74. Apostolova I, Irintchev A, Schachner M, (2006) Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice. J Neurosci 26: 7849-7859.
75. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, et al. (2006) Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23: 635-659.